Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: ?
Life Threatening? No
Write-up: This is a spontaneous report from a contactable other HCP who reported for a patient. A patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot number was not reported) on 17Apr2021 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. Historical vaccine included: bnt162b2 (COMIRNATY, Solution for injection,) dose 1 on 18Feb2021 04:00 PM, for covid-19 immunization. No prior cardiac past medical history. Medical history was not reported. Concomitant medications were not reported. On Patient received 2nd dose of Pfizer COVID-19 vaccine on 17Apr. That evening noticed SOB and chest tightness. Over the next 3 days went to ED with worsening CP. Found to have elevated troponins and EKG changes. CTPE negative. Symptoms improved with pain management, steroids, and colchicine. Cardiac MRI done on 23Apr that showed EF 52% and findings consistent with myocarditis and small pericardial effusion. Patient managed with ACE and colchicine. The clinical outcome of the events was unknown. Information on lot/ batch number has been requested.; Sender''s Comments: Based on the information provided, the contributory role of the suspect product second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot number was not reported) to reported events myocarditis and small pericardial effusion is possible. Case will be reassessed upon receipt of follow-up information.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166